CIGNA Member Correction

CIGNA members: Please note that you may receive a letter in the mail stating that The Dermatology Center of Indiana is no longer in your network. This communication from CIGNA is incorrect and we would like to reassure you that we are still in network with CIGNA. We look forward to continuing to service you and your family for all your dermatology needs.

Current Trials

Psoriasis
Sponsor: AbbVie
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis
18-99 Years
Phase: Phase 3
Start Date: February 2017
End Date: November 2021

Psoriasis
Sponsor: Janssen Research & Development, LLC
Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis
18 Years and Older
Phase: Phase 3
Start Date: February 2017
End Date: July 2018

Actinic Keratosis
Sponsor: DUSA Pharmaceuticals, Inc.
Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp
18 Years and Older
Phase: Phase 3
Start Date: March 2017
End Date: January 2018

Psoriasis
Sponsor: Janssen Research & Development, LLC
A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis
18 Years and Older
Phase: Phase 3
Start Date: April 2017
End Date: November 2018